Evidence map›Paper›PMID 30811035›Full record

ArticleTransfusion2019

Total plasma heme concentration increases after red blood cell transfusion and predicts mortality in critically ill medical patients.

Anthony P Pietropaoli, Kelly F Henrichs, Jill M Cholette, Sherry L Spinelli, Richard P Phipps, Majed A Refaai, Neil Blumberg

Open access · greenAbstract read
In one paragraph

Article in Transfusion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Linking Labile Heme with Thrombosis.Journal of clinical medicine · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anthony P PietropaoliDepartment of Medicine, Division of Pulmonary & Critical Care Medicine, University of Rochester Medical Center, Rochester, New York.
Kelly F HenrichsDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.
Jill M CholetteDepartment of Pediatrics, University of Rochester Medical Center, Rochester, New York.
Sherry L SpinelliDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.
Richard P PhippsDepartment of Medicine, Division of Pulmonary & Critical Care Medicine, University of Rochester Medical Center, Rochester, New York.
Majed A RefaaiDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.
Neil BlumbergDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.ORCID 0000-0002-2011-5652
University of Rochester Medical Center · US

Funding

Identification and Significance of Biologic Mediators in Red Cell ConcentratesR01HL095467 · NHLBI · UNIVERSITY OF ROCHESTER · PI BLUMBERG, NEIL, PHIPPS, RICHARD P. · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL095467NIH HHS HL095467NIH HHS NHLBI HL095467
6 · The paper itself

Abstract

backgroundRelationships between red blood cell (RBC) transfusion, circulating cell-free heme, and clinical outcomes in critically ill transfusion recipients are incompletely understood. The goal of this study was to determine whether total plasma heme increases after RBC transfusion and predicts mortality in critically ill patients. STUDY DESIGN AND

methodsThis was a prospective cohort study of 111 consecutive medical intensive care patients requiring RBC transfusion. Cell-free heme was measured in RBC units before transfusion and in the patients' plasma before and after transfusion.

resultsTotal plasma heme levels increased in response to transfusion, from a median (interquartile range [IQR]) of 35 (26-76) μmol/L to 47 (35-73) μmol/L (p < 0.001). Posttransfusion total plasma heme was higher in nonsurvivors (54 [35-136] μmol/L) versus survivors (44 [31-65] μmol/L, p = 0.03). Posttransfusion total plasma heme predicted hospital mortality (odds ratio [95% confidence interval] per quartile increase in posttransfusion plasma heme, 1.76 [1.17-2.66]; p = 0.007). Posttransfusion total plasma heme was not correlated with RBC unit storage duration and weakly correlated with RBC unit cell-free heme concentration.

conclusionsTotal plasma heme concentration increases in critically ill patients after RBC transfusion and is independently associated with mortality. This transfusion-associated increase in total plasma heme is not fully explained by RBC unit storage age or cell-free heme content. Additional studies are warranted to define mechanisms of transfusion-related plasma heme accumulation and test prevention strategies.

Indexed as

AdultAgedCohort StudiesCritical IllnessErythrocyte TransfusionFemaleHemeHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedPrognosisProspective StudiesTreatment OutcomeHeme

Identifiers

PMID30811035
PMCPMC6548617
OpenAlexW2916111082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.